Rutger-Jan Swijnenburg Profile
Rutger-Jan Swijnenburg

@rj_swijnenburg

Followers
30
Following
5
Media
0
Statuses
4

Joined June 2023
Don't wanna be here? Send us removal request.
@JAMAOnc
JAMA Oncology
1 year
CAIRO5 RCT: No overall survival benefit was found for different induction regimens in patients with initially unresectable colorectal cancer liver metastases; FOLFOX/FOLFIRI plus bevacizumab is recommended. https://t.co/StCVglNmpq
2
28
55
@MarcBesselink
Marc Besselink
2 years
Is ICG-fluorescence ๐ŸŸข useful during #robot ๐Ÿค– and laparoscopic #liver #surgery for #CRLM? Today #MIMIC trial in @JAMANetworkOpen @rj_swijnenburg ๐Ÿ”‘ Prosp study 225 pts, ICG-fluorescence imaging โฌ†๏ธ R0 resection and changed surgical management in 28% of pts. ๐Ÿ”‘ The absence of
2
18
50
@A2Schn
A2S
2 years
@ArndtVogel
Arndt Vogel
2 years
๐Ÿ”ฅFirst-line systemic treatment strategies in patients with initially unresectable #CRC liver metastases (CAIRO5) @TheLancetOncol https://t.co/pmBSQKVw7N ๐Ÿ…right-sided, mRAS or mBRAF CRC: FOLFOXIRI + Beva ๐Ÿ…left-sided, RAS & BRAF WT CRC: FOLFOX/FOLFIRI + Beva or Pani @myESMO
0
2
2
@VautheyMD
Jean-Nicolas Vauthey MD
2 years
Congratulations Dr. Swijnenburg for CAIRO-5 ๐Ÿ‡ณ๐Ÿ‡ฑ presentation @EAHPBA in Lyon ๐Ÿ‘ In unresectable #colorectalcancer #metastasis triplet FOLFOXIRI with bevacizumab or panitumumab better response, resectability and PFS than doublet #oncsurgery @SSATNews @SocSurgOnc @IHPBA @AHPBA
3
15
58